|1.||Sévigny, Jean: 11 articles (11/2015 - 11/2004)|
|2.||Meyer-Fernandes, José Roberto: 4 articles (05/2015 - 06/2006)|
|3.||Robson, Simon C: 4 articles (06/2012 - 03/2006)|
|4.||Meyer-Fernandes, J R: 3 articles (07/2014 - 03/2000)|
|5.||Lavoie, Elise G: 3 articles (04/2009 - 06/2005)|
|6.||Knowles, Aileen F: 3 articles (08/2008 - 10/2003)|
|7.||Dranoff, Jonathan A: 3 articles (03/2008 - 11/2004)|
|8.||Broekman, M Johan: 3 articles (01/2005 - 11/2002)|
|9.||Islam, Naziba: 3 articles (01/2005 - 11/2002)|
|10.||Drosopoulos, Joan H F: 3 articles (01/2005 - 11/2002)|
05/15/2006 - "CD39/ecto-NTPDase 1 (nucleoside triphosphate diphosphohydrolase 1) is an ecto-nucleotidase that influences P2 receptor activation to regulate vascular and immune cell adhesion and signalling events pivotal in inflammation. "
05/01/1998 - "Levamisole was administered at two doses: high (2.5 mg/kg) and low (0.25 mg/kg), according to two schedules: a) at a single dose, simultaneously with carragenine, 24 h before or 24 h after induction of inflammation; the lymphocytes were collected five times every 24 h, and the activity of ecto-ATPase was determined; b) at four doses, every 24 h after carragenine injection; the lymphocytes were collected 120 h after the induction of inflammation. "
06/01/2012 - "Overexpression of NTPDase2 in gliomas promotes systemic inflammation and pulmonary injury."
11/01/2015 - "Our results suggest that eATP, by upregulating NTPDase2 and eN and altering the enzyme membrane topology, affects local kinetics of ATP metabolism and signal transduction that may have important roles in the process related to inflammation and reactive gliosis. "
08/01/2009 - "These data suggest that the ADP derived from NTPDase2 activity stimulates platelet migration to the tumor area and that NTPDase2, by regulating angiogenesis and inflammation, seems to play an important role in tumor progression. "
05/01/1990 - "Our aim is to study the activity of ecto-adenosine triphosphatase in the heart damaged by ischemia. "
12/01/2012 - "Our results suggest that the ecto-ATPase activity of LLC-PK1 cells has the characteristics of a type 3 E-NTPDase which is inhibited by ischemia. "
03/01/2006 - "Ecto-nucleotidase biochemical activity of CD39 is lost at sites of acute vascular injury, such as in ischemia reperfusion and immune graft rejection. "
08/24/2012 - "Correspondingly, inhibition of ATP breakdown by addition of the selective ecto-ATPase inhibitor ARL67156 significantly reduced ischemia-induced apoptosis. "
08/24/2012 - "Addition of the soluble ecto-ATPase apyrase, enhancing ATP degradation, increased ischemia-induced caspase-3 cleavage. "
|3.||B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/01/1982 - "In the present studies, the properties of this ecto-nucleotidase were investigated in unhomogenized lymphocytes isolated from the blood of normal subjects and patients with chronic lymphocytic leukemia. "
01/01/1987 - "Cell membrane fluidity (CMF), Ig receptor expression and ecto-ATPase activity were investigated in lymphocytes from patients with chronic lymphocytic leukemia (CLL) and from healthy controls. "
|4.||Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
11/01/2004 - "The aim of this study was to assess the effect of experimental rat and disease-mediated human biliary cirrhosis on NTPDase2 expression in the liver. "
11/01/2004 - "Conversely, in non-biliary cirrhosis, NTPDase2 is shifted from the portal area to bridging fibrous bands. "
11/01/2004 - "Loss of NTPDase2 is a common pathway in both rat and human manifestations of biliary cirrhosis. "
11/01/2004 - "Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis."
03/01/2008 - "Since interleukin 6 (IL-6) is markedly upregulated in biliary cirrhosis, our aims were to determine the role and mechanism of IL-6 in the regulation of NTPDase2 by PF. "
|5.||B-Cell Leukemia (Leukemia, B Cell)
|1.||5'-Nucleotidase (5' Nucleotidase)
|2.||NG-Nitroarginine Methyl Ester (L-NAME)
|3.||Purinergic P2 Receptors (ADP Receptor)
|6.||Adenosine Triphosphate (ATP)
|8.||Adenosine Diphosphate (ADP)
|9.||Epidermal Growth Factor (EGF)